Minerva Surgical, Inc. has completed a pilot study assessing the feasibility of the Symphion® Bipolar Hysteroscopic Tissue Resection System in an office environment. The study involved 10 female participants and aimed to evaluate the safety and feasibility of the device for removing intracavitary polyps and myomas. Given the increasing trend towards outpatient procedures in gynecology, this device could capture a significant share of the market focused on minimally invasive treatments. However, the competitive landscape includes established players in the hysteroscopic device market, necessitating a robust marketing strategy and potential partnerships to enhance market penetration. Diligence should focus on regulatory pathways and reimbursement strategies to ensure commercial viability.